https://www.selleckchem.com/pr....oducts/Nanchangmycin
Primary outcome measures were cognitive function (measured using the Cambridge Neuropsychological Test Automated Battery (CANTA) and symptoms of depression (measured using the Beck Depression Inventory (BDI)) at 4weeks post-randomisation. Difficulties recruiting participants due to significant changes in the provision of inpatient care for alcohol dependence resulted in only 27 participants recruited to the trial, with data available for 21 participants. Fourteen participants were randomised to receive mifepristone and 13 to rec